A 28-year-old woman with a history of recurrent hypoglycemia during prolonged fasting is found to have elevated serum pyruvate (3.2 mmol/L, normal <0.1) and markedly elevated alanine (950 μmol/L, normal 300–500). Liver function tests and blood glucose are normal at rest. Which investigation would most specifically identify the enzyme defect in gluconeogenesis?
A. Plasma glucose and alanine ratio after a 12-hour fast with intravenous alanine challenge
B. Genetic sequencing of PCK2, FBP1, and G6PC genes
C. Liver biopsy with histochemistry and direct enzyme assay for PEPCK, FBPase-1, and G6Pase
D. Hepatic vein catheterization with arterio-venous glucose gradient measurement
Explanation
Confirmatory Investigation for Gluconeogenesis Enzyme Defects
Clinical Presentation Analysis
This patient has:
Fasting hypoglycemia (history of recurrent episodes)
Elevated pyruvate (substrate accumulation)
Elevated alanine (the primary gluconeogenic amino acid substrate)
Normal liver function (rules out hepatitis, cirrhosis)
Normal glucose at rest (suggests enzyme defect, not global hepatic dysfunction)
The pattern of pyruvate and alanine accumulation during fasting indicates that these substrates are being produced but cannot be efficiently converted to glucose — pathognomonic for gluconeogenesis enzyme deficiency.
Why Liver Biopsy with Enzyme Assay?
Key Point
Once biochemical testing (glucagon stimulation test, lactate/pyruvate ratios) has narrowed the diagnosis to a gluconeogenesis enzyme defect, direct enzyme assay on liver tissue is the gold standard confirmatory test because:
1.
Direct measurement of enzyme activity — quantifies residual PEPCK, FBPase-1, or G6Pase activity
2.
Identifies the specific enzyme deficient — critical for genetic counseling and prognosis
3.
Histochemistry — can show glycogen accumulation or fatty infiltration patterns specific to the defect
4.
Allows simultaneous assessment of all three key gluconeogenic enzymes in one sample
The alanine-to-pyruvate ratio is often elevated in PEPCK deficiency (alanine accumulates because pyruvate cannot be converted efficiently to oxaloacetate). In FBPase-1 deficiency, lactate is disproportionately elevated.
Why Not the Other Options?
Alanine challenge test (Option A):
Useful for functional assessment of gluconeogenesis capacity
Measures net hepatic glucose output (functional assessment)
Does not identify the specific enzyme responsible for the defect
Rarely used in modern practice
Genetic sequencing (Option D):
Confirmatory but not the first-line investigation
Useful for identifying mutations and genetic counseling
Requires enzyme assay or biochemical evidence to guide which genes to sequence
More expensive and time-consuming than enzyme assay
Should follow enzyme assay confirmation
Clinical Pearl
The diagnostic algorithm for gluconeogenesis defects: (1) Glucagon stimulation test or prolonged fast → (2) Liver biopsy with enzyme assay (confirmatory) → (3) Genetic sequencing (for mutation identification and counseling). Enzyme assay is the definitive confirmatory test because it directly measures the deficient activity.
Practice similar questions
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.
